Characterization of the modulation of the CYP3A4 activity by Efavirenz

被引：0
|
作者：
Hariparsad, N [1 ]
Nallani, SC [1 ]
Desai, PB [1 ]
机构：
[1] Univ Cincinnati, Med Ctr, Coll Pharm, Cincinnati, OH 45267 USA
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
158
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [1] Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity
    Westlind-Johnsson, A
    Hermann, R
    Huennemeyer, A
    Hauns, B
    Lahu, G
    Nassr, N
    Zech, K
    Ingelman-Sundberg, M
    von Richter, O
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (04) : 339 - 349
  • [2] Impact of long-term (14 days) efavirenz administration on CYP3A4 activity
    Heinrich, T.
    Roeder, C. S.
    Gehrig, A. K.
    Haefeli, W. E.
    Mikus, G.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 373 - 373
  • [3] Role of CYP3A4 in kinase inhibitor metabolism and assessment of CYP3A4 activity
    Mikus, Gerd
    Foerster, Kathrin Isabelle
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S1592 - S1599
  • [4] Modulation of Carbon Nanotubes' Perturbation to the Metabolic Activity of CYP3A4 in the Liver
    Zhang, Yi
    Wang, Yabin
    Liu, Aijuan
    Xu, Sherry Li
    Zhao, Bin
    Zhang, Yi
    Zou, Hanfa
    Wang, Wenyi
    Zhu, Hao
    Yan, Bing
    ADVANCED FUNCTIONAL MATERIALS, 2016, 26 (06) : 841 - 850
  • [5] CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity
    García-Martín, E
    Martínez, C
    Pizarro, RM
    García-Gamito, FJ
    Gullsten, H
    Raunio, H
    Agúndez, JAG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) : 196 - 204
  • [6] Decoding the selective chemical modulation of CYP3A4
    Jingheng Wang
    Stanley Nithianantham
    Sergio C. Chai
    Young-Hwan Jung
    Lei Yang
    Han Wee Ong
    Yong Li
    Yifan Zhang
    Darcie J. Miller
    Taosheng Chen
    Nature Communications, 16 (1)
  • [7] Pioglitazone: Effect on CYP3A4 activity
    Nowak, SN
    Edwards, DJ
    Clarke, A
    Anderson, GD
    Jaber, LA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (12): : 1299 - 1302
  • [8] Induction of CYP3A4 by efavirenz in primary human hepatocytes: Comparison with rifampin and phenobarbital
    Hariparsad, N
    Nallani, SC
    Sane, RS
    Buckley, DJ
    Buckley, AR
    Desai, PB
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (11): : 1273 - 1281
  • [9] Expression of CYP3A4 mRNA is correlated with CYP3A4 protein level and metabolic activity in human liver
    Watanabe, M
    Kumai, T
    Matsumoto, N
    Tanaka, M
    Suzuki, S
    Satoh, T
    Kobayashi, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 (04) : 459 - 462
  • [10] Effect of influenza immunization on CYP3A4 activity
    Hayney, MS
    Hammes, RJ
    Fine, JP
    Bianco, JA
    VACCINE, 2001, 20 (5-6) : 858 - 861
12345